1888PressRelease.com
1888 PressRelease Home Sign In Sign Up Contact Us About Us Sitemap

Intas Biopharmaceuticals Limited Company News Section

Intas Biopharmaceuticals Limited Information
Siddharth J. Baad
Phone: 00912717660208
Intas Biopharmaceuticals Limited (IBPL) has fully integrated biopharmaceutical operations at Ahmedabad, Gujarat. Since the launch of biotechnology operations in May 2000, Research & Development (R&D) and manufacturing of biopharmaceutical products with a special focus on Oncology (Cancer) are major thrust areas for the company. Being India’s first and only biopharmaceuticals company to receive EUROPEAN UNION – GOOD MANUFACTURING PRACTICE (EU-GMP) certification for its manufacturing facility, IBPL has carved a niche in the biopharmaceutical operations In terms of quality standards, the facility complies with strict international Good Manufacturing Practice regulations and conforms to guidelines laid down by WORLD HEALTH ORGANIZATION (WHO).
Intas Biopharmaceuticals Limited Press Release
07
May
Intas Plans Filgrastim Launch In North America, Europe
Intas Biopharma is a part of Cooperation between three continents for Biosimilar GCSF.

INTAS BIOPHARMACEUTICALS LIMITED (IBPL) signed business agreement with Canada–based APOTEX INC. for co-development and supply of its Filgrastim brand, ...